X0306 4 2015-04-10 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001410787 MDV IX LP C/O MOHR DAVIDOW VENTURES 3000 SAND HILL ROAD, SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001564546 Seventh MDV Partners, L.L.C. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001573991 Ninth MDV Partners, L.L.C. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001027621 FEIBER JONATHAN D 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001250354 SCHOENDORF NANCY J 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605837 MDV ENF VII (A), L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605838 MDV ENF VII (B), L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001605840 MDV VII Leaders' Fund, L.P. 3000 SAND HILL ROAD SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 0001129541 MDV VII LP C/O MOHR DAVIDOW VENTURES 3000 SAND HILL ROAD, SUITE 3-290 MENLO PARK CA 94025 0 0 1 0 Common Stock 2015-04-10 4 S 0 37078 18.557 D 462527 I MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF Common Stock 3772686 I MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP Common Stock 265150 I MDV VII, L.P. Common Stock 6043 I MDV ENF VII (A), L.P. Common Stock 3146 I MDV ENF VII (B), L.P. Common Stock 25661 I MDV VII Leaders' Fund, L.P. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by MDV IX on December 15, 2014. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $18.00 and $18.0900 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, "MDV IX"). William Ericson ("Ericson") and Jonathan Feiber ("Feiber") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports. Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, "MDV VII"). Feiber and Nancy Schoendorf ("Schoendorf") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports. Brett A. Teele 2015-04-14